Prof. Alaa Kandil

Alexandria School of Medicine, Egypt

Full professor

Email: [email protected]

Qualifications

1992 Ph.D., Alexandria School of Medicine, Egypt

1986 M.Sc., Alexandria University Hospitals, Egypt

Publications (Selected)

1. Kassem, L., Pöllinger, B., Velkovski-Rouyer, M., et al. (2025). Stage-Based Survival Analysis in the TRIple-Negative Breast Cancer PrOspective Registry in MiddLe East AfrIca (TRIPOLI) Study. Clinical Cancer Research, 31(12 Suppl), P5-11-26.
2. Kassem, L., Pöllinger, B., Velkovski-Rouyer, M., et al. (2025). Stage-Based Survival Analysis in the TRIple-Negative Breast Cancer PrOspective Registry in MiddLe East AfrIca (TRIPOLI) Study. Clinical Cancer Research, 31(12), Meeting Abstract P5-11-26.
3. Elghazaly, H., Azim, H. A., Rugo, H. S., et al. (2024). Tailoring neo/adjuvant systemic therapy in breast cancer: "The advent of a personalized approach"-The Breast-Gynecological and Immuno-Oncology International Cancer Conference (BGICC) consensus and recommendations. Cancer, 130(19), 3251–3271.
4. Alsaleh, K., Al Zahwahry, H., Bounedjar, A., et al. (2023). Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial. Journal of Cancer Research and Clinical Oncology, 149(9), 6171–6179.
5. Al-Saleh, K. A., El Zawahry, H. M., Bounedjar, A., et al. (2022). Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant. Journal of Clinical Oncology, 40(16 Suppl), Abstract 596.
6. Talaat, I. M., Yakout, N. M., Soliman, A. S. A., et al. (2022). Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study. Frontiers in Oncology, 12, Article 877147.
7. Elghazaly, H., Rugo, H. S., Azim, H. A., et al. (2021). Breast-Gynaecological & Immuno-Oncology International Cancer Conference (BGICC) Consensus and Recommendations for the Management of Triple-Negative Breast Cancer. Cancers, 13(9), Article 2262.
8. Azim, H. A., Kandil, A., El Zawahry, H., et al. (2021). Triple negative breast cancer prospective registry in middle East and Africa (TRIPOLI) study: Interim analysis of the patients' characteristics. Cancer Research, 81(4 Suppl), Meeting Abstract PS7-65.
9. Ahmed, R., Debian, H., Fawzi, M., et al. (2021). Diagnosis of Inflammatory Bowel Disease by Abdominal Ultrasound. Current Medical Imaging, 17(9), 1085–1093.
10. Talaat, I. M., Saber-Ayad, M., Yakout, N. M., et al. (2020). Exploring the Role of Galanin in Colorectal Cancer Progression: An Immunohistochemical and Transcriptomic Study. American Journal of Pathology, 190(12 Suppl), S2–S3.
11. Al-Saleh, K. A., Bounedjar, A., Oukkal, M., et al. (2020). Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial. Journal of Clinical Oncology, 38(15 Suppl), Abstract 594.
12. Guo, Y., Ahn, M. J., Chan, A. T. C., et al. (2019). Afatinib versus methotrexate as second-line treatment for patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) progressing on or after platinum-based therapy: LUX-Head & Neck 3 phase Ill trial. Journal of Clinical Oncology, 37(15 Suppl), Abstract 6024.
13. ElAlfy, E., ElKerm, Y., Zaky, S., & Kandil, A. (2011). IMPACT OF ADJUVANT CHEMOTHERAPY ON SURVIVAL OF PATIENTS WITH STAGE II COLON CANCER: RETROSPECTIVE STUDY. Annals of Oncology, 22(Suppl 5), v117–v118.
14. Abdelaziz, O. S., Abdelaziz, A., Rostom, Y., et al. (2011). LINAC Radiosurgery of Intracranial Arteriovenous Malformations: A Single-center Initial Experience. Neurosurgery Quarterly, 21(2), 85–96.
15. Abdelaziz, O. S., Kandil, A., El-Assaal, S., et al. (2011). Linear accelerator-based stereotactic radiosurgery of intracranial meningiomas: results of the first 5 years of clinical practice. Neurosurgical Review, 34(1), 87–96.
16. Kharboush, I. F., Ismail, H. M., Kandil, A. A., et al. (2011). Raising the Breast Health Awareness amongst Women in an Urban Slum Area in Alexandria, Egypt. Breast Care, 6(5), 375–379.
17. Abdalla, D., Hamza, M., Kandil, A., et al. (2009). MYCN GENE AMPLIFICATION AND DNA PLOIDY IN PERIPHERAL NEUROBLASTIC TUMORS. Pediatric Blood & Cancer, 53(5), 806.
18. Meshref, M. M., Samir, S., Saad, E., et al. (2009). A phase II trial of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer. Journal of Clinical Oncology, 27(15 Suppl), Abstract 1098.

Profile Details
https://scholar.google.com/citations?user=_W0Jb2cAAAAJ&hl=en
https://www.researchgate.net/profile/Alaa-Kandil-2

WOS ResearcherID: GCQ-0954-2022